AVGO vs CRM: Which Is the Better Buy?

Side-by-side comparison of Broadcom Inc. and Salesforce, Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-16.
Broadcom Inc. ยท Technology
$371.59
-49.9% upside to fair value
Grade C High Quality
VS
Salesforce, Inc. ยท Technology
$181.22
+161.6% upside to fair value
High Conviction Grade A-
QuantHub Verdict
CRM has more upside to fair value (+161.6%). CRM trades at a lower forward P/E (22.7x). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric AVGO CRM
Current Price $371.59 $181.22
Fair Value Estimate $186.35 $474.00
Upside to Fair Value -49.9% +161.6%
Market Cap $1,761.8B $169.8B
Forward P/E 70.7x 22.7x
EV / EBITDA 46.7x โ€”
Price / Sales 25.9x 4.1x
Price / FCF 61.1x 11.8x
Revenue Growth YoY +7.2% +9.2%
Gross Margin 67.1% 77.7%
Operating Margin 40.9% 21.5%
Return on Equity 32.9% 12.4%
Dividend Yield 0% โ€”
FCF Yield 1.64% 8.5%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
AVGO โ€” Broadcom Inc.
Broadcom Inc. is a leading technology company specializing in semiconductors and infrastructure software, with a strong competitive moat driven by scale, diversification, and aggressive M&A under CEO Hock E. Tan. The company has demonstrated robust revenue growth, particularly in semiconductor solutions and infrastructure software segments, with a 25% year-over-year increase recently and a five-yโ€ฆ
CRM โ€” Salesforce, Inc.
Salesforce is the leading global provider of CRM software, offering a strong competitive moat through market dominance and high switching costs, complemented by acquisitions like Slack and Tableau, with excellent margins above 77% gross and robust free cash flow of $15.16 per share. Despite decelerating revenue growth at 9.2% YoY and negative earnings growth of -6.9%, the business remains high-quโ€ฆ
Accumulation Zones
Metric AVGO CRM
Zone Low $139.76 $356.00
Zone High $158.40 $403.00
In Buy Zone? No Yes
โ† AVGO Research    CRM Research โ†’    All Research